Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ASCO '11: Roche, Avastin and Ovarian Cancer
The Street
Sunday, June 5, 2011 - 9:56am
tags:
Roche, Avastin, ovarian cancer
Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Menopause
news-medical.net
Saturday, June 4, 2011 - 11:24am
tags:
Bionovo, Menerba, menopause
'UK pharmaceutical industry in crisis'
Press TV
Saturday, June 4, 2011 - 11:23am
tags:
UK
Mylan receives US FDA nod for generic Effexor XR capsules
Pharmabiz
Saturday, June 4, 2011 - 11:15am
tags:
Mylan, Effexor XR
Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without their disease getting worse
Pipeline Review
Saturday, June 4, 2011 - 11:13am
tags:
Tarceva, lung cancer
Takeda Drops Suit Over Macleods' Actos ANDA
Law360
Saturday, June 4, 2011 - 11:06am
tags:
Takeda, Actos, Macleod
Forest Laboratories - Best Performing Pharmaceutical
Trader's Huddle
Saturday, June 4, 2011 - 11:04am
tags:
Forest Labs
Five-Year Follow-Up Data for SPRYCEL® (dasatinib) 100 mg Once Daily Demonstrated 78 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant or Intolerant to Gleevec®*
BusinessWire
Saturday, June 4, 2011 - 10:53am
tags:
Sprycel, Bristol-Myers Squibb, leukemia
Pfizer And Big Pharma Peers Eye Post-Blockbuster Era
Investor's Business Daily
Saturday, June 4, 2011 - 10:34am
tags:
Pfizer, Big Pharma
Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Reduction in Life-Threatening Venous Thrombo-Embolism
Yahoo/PR NewsWire
Saturday, June 4, 2011 - 10:29am
tags:
Sanofi, Semuloparin, Venous Thrombo-Embolism
J&J Ordered to Pay $327 Million Over Deceptive-Marketing Claims
Bloomberg
Saturday, June 4, 2011 - 10:26am
tags:
JNJ, Risperdal, legal
Cancer-Drug Trials Matching Medicines to Mutations Boost Odds of Success
Bloomberg
Saturday, June 4, 2011 - 10:25am
tags:
cancer
A Hazy Future For Big Pharma
Yahoo/Investor's Business Daily
Saturday, June 4, 2011 - 10:08am
tags:
Big Pharma
FDA Bullies Obesity Drugmakers
Motley Fool
Saturday, June 4, 2011 - 10:06am
tags:
Orexigen, Contrave, Vivus, Qnexa, Arena Pharmaceuticals, obesity, weight loss
ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
Yahoo/BusinessWire
Saturday, June 4, 2011 - 10:03am
tags:
Immunogen, SAR3419, non-Hodgkin's lymphoma
Medivation and Astellas Announce New Study Results Confirming Clinical Effects and Tolerability of MDV3100 in Advanced Prostate Cancer
Yahoo/MarketWire
Saturday, June 4, 2011 - 10:01am
tags:
Medivation, Astellas, MDV3100, prostate cancer
EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients
Yahoo/PR NewsWire
Saturday, June 4, 2011 - 9:57am
tags:
EntreMed, ENMD-2076, ovarian cancer
Orexigen puts obesity drug development on hold
Yahoo/AP
Saturday, June 4, 2011 - 9:51am
tags:
Orexigen, obesity, weight loss, Contrave
J&J Must Pay $327 Million Over Deceptive-Marketing Claims
Bloomberg
Friday, June 3, 2011 - 6:51pm
tags:
JNJ, settlements, Risperdal, antipsychotics, Ortho-McNeil-Janssen
Rx For Amgen: Issue Dividend
Motley Fool
Friday, June 3, 2011 - 6:49pm
tags:
dividends, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.